Thermo Fisher Scientific Announces New Chemiluminescent Option for Western Blot Detection

ROCKFORD, Ill. (April 12, 2011) – Thermo Fisher Scientific, the world leader in serving science, today introduced Thermo Scientific Pierce ECL Plus Substrate for Western blotting detection. The Pierce® ECL Plus Substrate is a highly sensitive, acridan-based reagent used for the chemiluminescent or chemifluorescent horseradish peroxidase detection of immunoblots.

The Pierce ECL Plus Substrate detects low picogram level of antigen, which can be visualized on X-ray film or with an imaging system. The long-lasting signal generated using the Pierce ECL Plus Substrate can be detected easily for up to five hours, and up to 20 hours with longer exposure times. The substrate is compatible with both PVDF and nitrocellulose membranes.

The substrate is available in two sizes, with reagent sufficient for 250 or 1,000 squared centimeters of membrane. For more information on the Pierce ECL Plus Western Blotting Substrate, please visit www.thermoscientific.com/pierce.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com

Back to news